← Back to Directory

Lakewood-Amedex Biotherapeutics, Inc. (LABT) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Lakewood-Amedex Biotherapeutics, Inc. (LABT).

Download StockRank on Google Play Download StockRank on the App Store

Equity Details

Price & Market Data

Price: $3.16

Daily Change: $0.00 / 0.00%

Daily Range: $3.10 - $3.32

Market Cap: $46,111,580

Daily Volume: 224,529

Performance Metrics

1 Week: 3.87%

1 Month: -59.75%

3 Months: -59.75%

6 Months: -59.75%

1 Year: -59.75%

YTD: -62.77%

About Lakewood-Amedex Biotherapeutics, Inc. (LABT)

Key metrics for Lakewood-Amedex Biotherapeutics, Inc. (LABT). Current price: 3.16, daily change: $0.00 / 0.00%. Market cap: 46,111,580. Performance across all periods for quick analysis.

Company Details

Employees: 5

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin® class, a novel class of antimicrobial agents that fight infections by disrupting microbial membranes. It develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers. Lakewood-Amedex Biotherapeutics, Inc. was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June, 2025. The company was incorporated in 2006 and is headquartered in University Park, Florida.

Selected stocks

First Citizens BancShares, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 5.375% Non-Cumulative Perpetual Preferred Stock, Series A (FCNCP)

Church & Dwight Company, Inc. (CHD)

Western Asset Global High Income Fund Inc (EHI)

StubHub Holdings, Inc. (STUB)

uCloudlink Group Inc. (UCL)